- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有204家主力机构披露2026-06-30报告期持股数据，持仓量总计4.52亿股，占流通A股79.02%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了75%的股票
技术面评分前10的股票
近期的平均成本为33.64元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为33.64元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"33.64","date":1791361509,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2026.10.08","stock":"-2.55","trade":null,"ind":"-0.79"},{"date":"2026.09.30","stock":"1.40","trade":null,"ind":"0.31"},{"date":"2026.09.29","stock":"-1.52","trade":null,"ind":"0.18"},{"date":"2026.09.28","stock":"1.43","trade":null,"ind":"-1.67"},{"date":"2026.09.24","stock":"-2.29","trade":null,"ind":"-1.22"},{"date":"2026.09.23","stock":"-1.52","trade":null,"ind":"-0.39"},{"date":"2026.09.22","stock":"7.53","trade":null,"ind":"0.06"},{"date":"2026.09.21","stock":"1.09","trade":null,"ind":"0.97"},{"date":"2026.09.18","stock":"0.03","trade":null,"ind":"0.94"},{"date":"2026.09.17","stock":"0.78","trade":null,"ind":"-0.41"},{"date":"2026.09.16","stock":"0.57","trade":null,"ind":"0.71"},{"date":"2026.09.15","stock":"0.00","trade":null,"ind":"-0.54"},{"date":"2026.09.14","stock":"1.89","trade":null,"ind":"-0.07"},{"date":"2026.09.11","stock":"-3.08","trade":null,"ind":"-1.18"},{"date":"2026.09.10","stock":"0.22","trade":null,"ind":"-0.43"},{"date":"2026.09.09","stock":"-0.53","trade":null,"ind":"0.28"},{"date":"2026.09.08","stock":"-0.86","trade":null,"ind":"0.20"},{"date":"2026.09.07","stock":"-1.43","trade":null,"ind":"0.07"},{"date":"2026.09.04","stock":"1.82","trade":null,"ind":"-0.30"},{"date":"2026.09.03","stock":"-1.70","trade":null,"ind":"0.02"},{"date":"2026.09.02","stock":"-0.42","trade":null,"ind":"-0.97"}]
安图生物,上证指数,医疗器械指数
压力支撑
该股压力位为33.68元，支撑位为32.87元。
[{"text":"\u538b\u529b\u4f4d","value":"33.68","date":1791388800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"32.87","date":1791388800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.7资金面打败了92%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月08日 20:31
| 机构今日流向(万元) | -1488.55 | 机构5日流向(万元) | -2454.61 |
| 机构10日流向(万元) | -477.57 | 机构20日流向(万元) | -2675.68 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加162.70万股，其中基金净增仓6家，主力净增仓15家，有一定的中长期投资价值。
截止2026-06-30，共204家主力机构（基金201家，一般法人3家），持仓量总计45154.75万股，占流通A股79.02%
其中，基金持仓与2025-12-31相比：
增仓：63家 ，增持 276.25万股
减仓：57家 ，减持 497.41万股
新出现在主力名单中：64家 ，持有857.69万股
从主力名单中消失：49家 ，原持有352.56万股
其中，基金持仓与2025-12-31相比：
增仓：63家 ，增持 276.25万股
减仓：57家 ，减持 497.41万股
新出现在主力名单中：64家 ，持有857.69万股
从主力名单中消失：49家 ，原持有352.56万股
消息面诊股
诊断结果：5.5消息面打败了66%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 上半年业绩下滑，安图生物称全年毛利率或上升
2026-10-07 - 安图生物：9月30日获融资买入581.84万元
2026-10-01 - 安图生物：全资子公司完成2项许可证变更登记
2026-09-30 - 安图生物：9月29日获融资买入1173.34万元
2026-09-30 - 9月QFII调研偏爱三大行业
2026-09-29 - 安图生物：9月28日获融资买入1427.53万元
2026-09-29 - 不赚钱的客户不要了：17家上市械企集中做减法
2026-09-28 - 安图生物：9月24日获融资买入2464.06万元
2026-09-25 - 券商观点|医疗器械行业投资策略：医疗器械板块业绩复
2026-09-24 - 安图生物：9月23日获融资买入2170.24万元
2026-09-24
消息列表
| 一般消息 | 募资投向 | 2026-09-17 | |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-25 |
| 一般消息 | 高管变动 | 工作调整 | 2026-04-23 |
| 利好 | 分红转增 | 10派13.10元(含税) | 2026-04-23 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了9%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.10.08","price":"-0.79","value":null},{"date":"2026.09.30","price":"0.31","value":null},{"date":"2026.09.29","price":"0.18","value":null},{"date":"2026.09.28","price":"-1.67","value":null},{"date":"2026.09.24","price":"-1.22","value":null},{"date":"2026.09.23","price":"-0.39","value":null},{"date":"2026.09.22","price":"0.06","value":null},{"date":"2026.09.21","price":"0.97","value":null},{"date":"2026.09.18","price":"0.94","value":null},{"date":"2026.09.17","price":"-0.41","value":null},{"date":"2026.09.16","price":"0.71","value":null},{"date":"2026.09.15","price":"-0.54","value":null},{"date":"2026.09.14","price":"-0.07","value":null},{"date":"2026.09.11","price":"-1.18","value":null},{"date":"2026.09.10","price":"-0.43","value":null},{"date":"2026.09.09","price":"0.28","value":null},{"date":"2026.09.08","price":"0.20","value":null},{"date":"2026.09.07","price":"0.07","value":null},{"date":"2026.09.04","price":"-0.30","value":null},{"date":"2026.09.03","price":"0.02","value":null},{"date":"2026.09.02","price":"-0.97","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 采纳股份 | 60.12% | 7.67% | 5.4分 |
| 2 | 洁特生物 | 57.26% | 5.29% | 4.1分 |
| 3 | 五洲医疗 | 41.03% | 21.30% | 4.9分 |
| 4 | 中红医疗 | 22.07% | 5.99% | 5.2分 |
| 5 | 艾德生物 | 21.30% | -0.81% | 5.5分 |
| 6 | 浩欧博 | 17.63% | -10.30% | 4.8分 |
| 8 | 奥精医疗 | 14.70% | -10.19% | 4.3分 |
| 10 | 海尔生物 | 11.92% | -0.91% | 5.5分 |
| 12 | 东富龙 | 11.46% | -2.27% | 5.0分 |
| 14 | 蓝帆医疗 | 10.22% | 12.29% | 6.1分 |
| 16 | 之江生物 | 9.64% | -3.82% | 4.6分 |
| 18 | 戴维医疗 | 8.44% | 0.79% | 5.3分 |
| 20 | 拱东医疗 | 8.31% | -1.28% | 4.8分 |
| 22 | 安杰思 | 6.63% | -2.89% | 4.9分 |
| 24 | 安必平 | 6.19% | -2.49% | 5.1分 |
| 26 | 圣湘生物 | 4.83% | -0.48% | 4.7分 |
| 28 | 南微医学 | 4.32% | -4.71% | 5.4分 |
| 30 | 正海生物 | 3.93% | 1.67% | 5.1分 |
| 32 | 九强生物 | 3.11% | 0.76% | 5.1分 |
| 34 | 透景生命 | 2.66% | -8.30% | 5.2分 |
| 36 | 迈克生物 | 2.28% | 0.21% | 5.0分 |
| 38 | 新华医疗 | 2.20% | -0.08% | 5.3分 |
| 40 | 港通医疗 | 1.92% | -2.75% | 5.0分 |
| 42 | 利德曼 | 1.17% | 1.17% | 4.2分 |
| 44 | 爱威科技 | 0.88% | 0.75% | 5.2分 |
| 46 | 安图生物 | 0.79% | -3.57% | 5.3分 |
| 48 | 三诺生物 | 0.38% | -2.08% | 5.7分 |
| 50 | 硕世生物 | 0.15% | -2.40% | 4.7分 |
| 52 | 黄山胶囊 | -0.15% | 1.19% | 5.2分 |
| 54 | 昊海生科 | -0.23% | -2.04% | 5.1分 |
| 56 | 西山科技 | -0.30% | -4.03% | 3.8分 |
| 58 | 康为世纪 | -0.51% | -10.21% | 4.4分 |
| 60 | 中源协和 | -0.85% | -2.96% | 5.2分 |
| 62 | 阳普医疗 | -1.15% | 0.73% | 5.6分 |
| 64 | 冠昊生物 | -1.52% | -3.39% | 5.3分 |
| 66 | 天智航 | -1.59% | -6.13% | 4.4分 |
| 68 | 祥生医疗 | -1.73% | -5.32% | 5.5分 |
| 70 | 三友医疗 | -1.96% | -1.67% | 5.0分 |
| 72 | 天益医疗 | -2.08% | -2.87% | 5.3分 |
| 74 | 维力医疗 | -2.28% | 0.81% | 5.3分 |
| 76 | 瑞迈特 | -2.55% | -1.22% | 5.0分 |
| 78 | 易瑞生物 | -2.84% | -1.51% | 4.7分 |
| 80 | 健帆生物 | -2.91% | -1.12% | 5.1分 |
| 82 | 乐普医疗 | -3.05% | -1.04% | 5.0分 |
| 84 | 开立医疗 | -3.12% | -4.25% | 4.6分 |
| 86 | 东星医疗 | -3.23% | -7.63% | 4.1分 |
| 88 | 麦澜德 | -3.38% | -5.92% | 4.0分 |
| 90 | 新产业 | -3.49% | -0.08% | 5.1分 |
| 92 | 理邦仪器 | -3.95% | -2.22% | 4.8分 |
| 94 | 麦克奥迪 | -4.42% | -3.91% | 4.5分 |
| 96 | 超研股份 | -4.66% | -4.08% | 5.2分 |
| 98 | 赛诺医疗 | -4.93% | -2.03% | 4.6分 |
| 100 | 迈瑞医疗 | -5.40% | 1.38% | 5.4分 |
| 102 | 美好医疗 | -5.47% | -9.69% | 4.3分 |
| 104 | 万东医疗 | -5.72% | -1.89% | 5.2分 |
| 106 | 北芯生命 | -6.05% | -7.16% | 5.8分 |
| 108 | 国发股份 | -6.09% | -0.83% | 3.9分 |
| 110 | - | -6.89% | -3.81% | 分 |
| 112 | - | -7.51% | -3.67% | 分 |
| 114 | 英诺特 | -8.03% | -9.41% | 4.0分 |
| 116 | 热景生物 | -8.52% | -10.45% | 4.4分 |
| 118 | - | -9.19% | -3.64% | 分 |
| 120 | 爱朋医疗 | -9.76% | -5.15% | 4.6分 |
| 122 | - | -10.39% | -2.93% | 分 |
| 124 | 澳华内镜 | -11.02% | -6.89% | 4.1分 |
| 126 | 康众科技 | -11.70% | -9.62% | 3.4分 |
| 128 | 山外山 | -12.05% | -7.80% | 4.6分 |
| 130 | 奕瑞科技 | -13.19% | -16.20% | 4.0分 |
| 132 | - | -13.83% | -5.37% | 分 |
| 134 | 南卫股份 | -15.06% | -10.86% | 3.0分 |
| 136 | 海泰新光 | -15.98% | -20.76% | 4.2分 |
| 138 | - | - | 0.45% | 分 |
| 140 | - | - | -22.11% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 24/244 ， 28/244。
[{"date":"2026-06-30","value":"5.65","vol":"2.35"},{"date":"2026-03-31","value":"2.61","vol":"1.12"},{"date":"2025-12-31","value":"12.18","vol":"2.37"},{"date":"2025-09-30","value":"9.90","vol":"3.06"},{"date":"2025-06-30","value":"6.69","vol":"2.40"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.65 | 2.61 | 12.18 | 9.90 | 6.69 |
| 行业(%) | 2.35 | 1.12 | 2.37 | 3.06 | 2.40 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"67.25","vol":"52.38"},{"date":"2026-03-31","value":"66.64","vol":"52.12"},{"date":"2025-12-31","value":"65.64","vol":"51.82"},{"date":"2025-09-30","value":"64.83","vol":"52.03"},{"date":"2025-06-30","value":"64.43","vol":"52.36"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
67.25 | 66.64 | 65.64 | 64.83 | 64.43 |
| 行业(%) | 52.38 | 52.12 | 51.82 | 52.03 | 52.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 81/244 ， 78/244。
[{"date":"2026-06-30","value":"-0.12","vol":"5.46"},{"date":"2026-03-31","value":"-0.37","vol":"5.59"},{"date":"2025-12-31","value":"-5.47","vol":"1.01"},{"date":"2025-09-30","value":"-7.48","vol":"0.11"},{"date":"2025-06-30","value":"-6.65","vol":"-1.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.12 | -0.37 | -5.47 | -7.48 | -6.65 |
| 行业(%) | 5.46 | 5.59 | 1.01 | 0.11 | -1.37 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-12.94","vol":"-24.55"},{"date":"2026-03-31","value":"-12.39","vol":"-20.93"},{"date":"2025-12-31","value":"-10.59","vol":"-33.44"},{"date":"2025-09-30","value":"-10.11","vol":"-15.21"},{"date":"2025-06-30","value":"-7.83","vol":"-17.88"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-12.94 | -12.39 | -10.59 | -10.11 | -7.83 |
| 行业(%) | -24.55 | -20.93 | -33.44 | -15.21 | -17.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 60/244 ， 89/244。
[{"date":"2026-06-30","value":"0.17","vol":"0.17"},{"date":"2026-03-31","value":"0.08","vol":"0.08"},{"date":"2025-12-31","value":"0.35","vol":"0.35"},{"date":"2025-09-30","value":"0.27","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.08 | 0.35 | 0.27 | 0.18 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.25 | 0.17 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.69","vol":"1.12"},{"date":"2026-03-31","value":"0.35","vol":"0.55"},{"date":"2025-12-31","value":"1.39","vol":"2.33"},{"date":"2025-09-30","value":"1.01","vol":"1.66"},{"date":"2025-06-30","value":"0.65","vol":"1.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.69 | 0.35 | 1.39 | 1.01 | 0.65 |
| 行业(次) | 1.12 | 0.55 | 2.33 | 1.66 | 1.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 96/244 ， 61/244。
[{"date":"2026-06-30","value":"6.50","vol":"14.81"},{"date":"2026-03-31","value":"14.77","vol":"-0.33"},{"date":"2025-12-31","value":"45.15","vol":"32.14"},{"date":"2025-09-30","value":"40.80","vol":"14.86"},{"date":"2025-06-30","value":"22.91","vol":"15.69"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 6.50 | 14.77 | 45.15 | 40.80 | 22.91 |
| 行业 | 14.81 | -0.33 | 32.14 | 14.86 | 15.69 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.95","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.23","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.32","vol":"1.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.95 | - | 1.23 | - | 1.32 |
| 行业 | 1.31 | 0.00 | 1.62 | 0.01 | 1.58 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/244 ， 7/244。
[{"date":"2026-06-30","value":"2.42","vol":"5.78"},{"date":"2026-03-31","value":"2.67","vol":"6.17"},{"date":"2025-12-31","value":"2.40","vol":"5.27"},{"date":"2025-09-30","value":"2.58","vol":"5.64"},{"date":"2025-06-30","value":"2.34","vol":"5.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.42 | 2.67 | 2.40 | 2.58 | 2.34 |
| 行业 | 5.78 | 6.17 | 5.27 | 5.64 | 5.45 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.08","vol":"4.71"},{"date":"2026-03-31","value":"0.95","vol":"5.04"},{"date":"2025-12-31","value":"0.88","vol":"4.13"},{"date":"2025-09-30","value":"0.92","vol":"4.49"},{"date":"2025-06-30","value":"0.85","vol":"4.34"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.08 | 0.95 | 0.88 | 0.92 | 0.85 |
| 行业 | 4.71 | 5.04 | 4.13 | 4.49 | 4.34 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 49/244 ， 50/244。
[{"date":"2026-06-30","value":"25.60","vol":"23.17"},{"date":"2026-03-31","value":"24.40","vol":"22.26"},{"date":"2025-12-31","value":"26.64","vol":"23.19"},{"date":"2025-09-30","value":"24.57","vol":"22.23"},{"date":"2025-06-30","value":"26.57","vol":"22.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
25.60 | 24.40 | 26.64 | 24.57 | 26.57 |
| 行业(%) | 23.17 | 22.26 | 23.19 | 22.23 | 22.18 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.35","vol":"0.42"},{"date":"2026-03-31","value":"0.33","vol":"0.40"},{"date":"2025-12-31","value":"0.37","vol":"0.41"},{"date":"2025-09-30","value":"0.33","vol":"0.72"},{"date":"2025-06-30","value":"0.37","vol":"0.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.35 | 0.33 | 0.37 | 0.33 | 0.37 |
| 行业(%) | 0.42 | 0.40 | 0.41 | 0.72 | 0.58 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中原证券 | 2026-09-22 | 增持 | |
| 华创证券 | 2026-09-17 | 增持 | |
| 申万宏源 | 2026-09-08 | 买入 | |
| 华泰证券 | 2026-09-04 | 买入 | 买入 |
| 国联民生 | 2026-08-29 | 买入 | |
| 中国银河 | 2026-08-28 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"11.67","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"12.17","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.94","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"10.68","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"11.16","blueLineValue":"1.95","type":"YC"}]